LivaNova Quarterly Cash Flow Statement
NASDAQ: LIVNHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
LivaNova free cash flow
In the quarter ended Jun 30, 2026, LivaNova generated $66.6 million of operating cash flow and spent $31.6 million on capital expenditures. That left free cash flow of $35.0 million, a free-cash-flow margin of 9.0% of revenue. Free cash flow was down 26.7% from the prior year's $47.8 million.
Summary generated from market data by MetaCap's automated system. Methodology
LivaNova cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 108.57M | 22.29M | 30.91M | 26.78M | 27.16M | -327.32M | 55.89M | 32.95M | 16.33M | -41.94M | 16.34M | -7.32M |
| Net Income growth (YoY) | +299.72% | — | -44.70% | -18.72% | +66.30% | — | +242.07% | — | +1314.11% | -669.10% | +883.68% | — |
| Depreciation & Amortization | 8.75M | 8.30M | 7.55M | 7.71M | 6.87M | 6.42M | 6.42M | 6.24M | 6.17M | 6.27M | 6.16M | 6.54M |
| Stock-Based Compensation | 16.88M | 8.27M | 9.39M | 9.95M | 9.17M | 7.78M | 6.95M | 8.56M | 8.20M | 10.23M | 8.28M | 11.78M |
| Change in Working Capital | -24.33M | -20.41M | -14.11M | 20.82M | 15.78M | 47.00K | 13.97M | -5.41M | 9.19M | -15.10M | 2.20M | -9.78M |
| Operating Cash Flow | 66.59M | 15.22M | 82.40M | 85.06M | 62.92M | 23.97M | 78.71M | 50.99M | 43.36M | 9.98M | 53.96M | 18.14M |
| Capital Expenditures | -31.55M | -14.29M | -32.23M | -22.88M | -15.15M | -10.79M | -10.41M | -18.15M | -12.16M | -6.40M | -12.92M | -8.72M |
| Investing Cash Flow | -31.92M | -14.58M | -30.26M | -23.06M | -8.97M | -10.63M | -10.71M | -18.52M | -12.57M | -6.36M | -12.14M | -10.05M |
| Debt Issued | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 335.51M | 0 | 0 |
| Debt Repaid | 0 | -95.94M | -64.11M | -6.56M | -205.88M | -4.38M | -4.37M | -4.42M | -4.38M | -234.38M | -5.56M | -4.25M |
| Financing Cash Flow | -56.45M | -94.25M | -62.88M | -9.37M | -208.98M | -4.42M | -3.44M | -3.28M | -11.87M | 37.15M | -5.02M | -4.28M |
| Net Change in Cash | -23.09M | -95.85M | -10.53M | 52.44M | -144.80M | 14.88M | 56.98M | 33.45M | 17.44M | 37.81M | 45.15M | -1.64M |
| Free Cash Flow | 35.04M | 926.00K | 50.16M | 62.18M | 47.77M | 13.18M | 68.30M | 32.85M | 31.20M | 3.58M | 41.04M | 9.42M |
This table shows 12 quarterly periods of LivaNova's cash flow statement, from Q2 2026 back to Q3 2023, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow LIVN's reporting calendar. What is a cash flow statement?